Department of Radiology

Publications

2019

Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, et al. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas. J Neuroimaging. 2019;29(5):650-656.

Amor-Coarasa A, Kelly JM, Babich JW. 3D-printed automation for optimized PET radiochemistry. Sci Adv. 2019;5(9):eaax4762.

Moghadam AA, Caprio A, Alaie S, Min JK, Dunham S, Mosadegh B. Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots. J Vis Exp. 2019;(153).

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019;142(1):133-145.

Guo Y, Liu Z, Wen Y, Spincemaille P, Zhang H, Jafari R, et al. Quantitative susceptibility mapping of the spine using in-phase echoes to initialize inhomogeneous field and R2* for the nonconvex optimization problem of fat-water separation. NMR Biomed. 2019;32(11):e4156.

S Bandt K, de Rochefort L, Chen W, Dimov AV, Spincemaille P, Kopell BH, et al. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice. World Neurosurg. 2019;122:e10-e19.

Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, et al. Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using Zr-DFO-MSTP2109A Anti-STEAP1 Antibody. J Nucl Med. 2019;60(11):1517-1523.

Niogi SN, Luther N, Kutner K, Shetty T, McCrea HJ, Barnes R, et al. Increased sensitivity to traumatic axonal injury on postconcussion diffusion tensor imaging scans in National Football League players by using premorbid baseline scans. J Neurosurg. 2019:1-9.

Varangis E, Razlighi Q, Habeck CG, Fisher Z, Stern Y. Between-network Functional Connectivity Is Modified by Age and Cognitive Task Domain. J Cogn Neurosci. 2019;31(4):607-622.

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, et al. Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). J Alzheimers Dis. 2019;67(2):685-705.